Antineoplaston Therapy in Treating Women With Advanced Breast Cancer

NCT00003455 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Stage IV Breast Cancer
Recurrent Breast Cancer

Interventions

DRUG: antineoplaston A10
DRUG: antineoplaston AS2-1
PROCEDURE: alternative product therapy
PROCEDURE: biological therapy
PROCEDURE: biologically based therapies
PROCEDURE: cancer prevention intervention
PROCEDURE: complementary and alternative therapy
PROCEDURE: differentiation therapy

Sponsor

Burzynski Research Institute